AKRX/Fresenius: Severity of FDA Violations Will Determine Any Finding of Materiality in Merger Termination Trial

The dispute between Akorn and Fresenius will be focused on whether Akorn has violated any FDA regulations and the impact on operations…

Read more

COL/UTX: Deal in Final Weeks of China’s SAMR Review

A plan by United Technologies to buy smaller peer Rockwell Collins is in the final weeks of merger review in China, given that the notification…

Read more

NXPI/QCOM: China ‘Highly Appreciates’ Trump’s Move on ZTE, Promises to Take Stock of US Concerns

China said it “highly appreciates” U.S. President Donald Trump’s latest remarks on the ZTE issue, marking the most positive response yet from…

Read more

AET/CVS and ESRX/CI: Trump’s Drug Pricing Speech To Target Rebates, Unlikely to Impact PBM-Insurer Deals

During a press call on the evening of May 10, a senior administration official touted President Trump’s FY19 budget…

Read more

AKRX/Fresenius: Dispute Will Center on Materiality of Alleged FDA Data Integrity Issues

The dispute between Akorn and Fresenius over whether the Delaware Chancery should order the parties to complete…

Read more

NXPI/QCOM: MOFCOM Says China Holds ‘Solemn’ Stance Against ZTE Ban

China’s Ministry of Commerce, or MOFCOM, has made “solemn representations” to the U.S. about America’s exports…

Read more

MON/BAYN: DOJ on Track to Announce Decision Toward End of May

The DOJ has begun working on its consent decree package for the Monsanto/Bayer transaction. In cases where the agency enters into a…

Read more

TRCO/SBGI: DOJ Consent Decree Process to Begin in Coming Weeks

Sinclair and the DOJ have reached an understanding on which stations need to be sold, according to a person with knowledge of the transaction…

Read more

AKRX/Fresenius: Court Date To Come Quickly as Akorn Seeks Order Forcing Fresenius To Complete Deal

Akorn will most likely request that the court compel “specific performance” from Fresenius requiring the company to complete the merger as originally…

Read more

AET/CVS and ESRX/CI: PSAOs Weakening as Counterbalance to PBMs

Independent pharmacies have exercised significant countervailing buyer power as a result of their ability to act collectively…

Read more